Home›Stock Screener›Shree Ganesh Remedies

Shree Ganesh Remedies Share Price Today | Stock Price & Shree Ganesh Remedies Share Screener

SGRL Pharmaceuticals & Biotechnology
Live Share Price NSE
₹616.60
▼ -1.05 (-0.17%)
2026-11-17 00:00:00
Live Share Price BSE
₹615.05
▼ -1.40 (-0.23%)
2026-11-17 00:00:00

As of November 17, 2026, the live Shree Ganesh Remedies share price (NSE: SGRL) is ₹616.60 on NSE and ₹615.05 on BSE, down 0.17% from the previous close, with shares trading between ₹611.00 and ₹628.00 in today's trading session, and a 52-week range of ₹501.05–₹735.55. Track Shree Ganesh Remedies networth to gauge the company's total market size. Use the Shree Ganesh Remedies stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Shree Ganesh Remedies opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹34 and net income of ₹6, with EBITDA of ₹12, an operating margin of 34.0% and a profit margin of 17.7%.

Shree Ganesh Remedies Market Cap ₹793.07 Cr.
SGRL P/E Ratio (TTM) 65.40
Shree Ganesh Remedies P/B Ratio 4.77
EPS (TTM) ₹13.83
Dividend Yield 0.08%
Debt to Equity 0.22
SGRL 52 Week High ₹735.55
Shree Ganesh Remedies 52 Week Low ₹501.05
Operating Margin 34.00%
Profit Margin 17.65%
SGRL Revenue (TTM) ₹34.00
EBITDA ₹12.00
Net Income ₹6.00
Total Assets ₹208.00
Total Equity ₹163.00

Shree Ganesh Remedies Share Price Chart

Track the current stock price of Shree Ganesh Remedies with an interactive chart. Analyse SGRL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Shree Ganesh Remedies stock quote in one place.

The quote of ₹616.60 sits between the 52-week low of ₹501.05 and the 52-week high of ₹735.55, and the latest session moved -0.17% from the previous close.

Shree Ganesh Remedies Company Profile - Fundamental Screener

Screen Shree Ganesh Remedies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SGRL shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE414Y01015.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE414Y01015

Shree Ganesh Remedies Balance Sheet Screener

Screen SGRL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹208, up from ₹192 in 2025.

Latest statistics put total assets at ₹208 and shareholder funds at ₹163, with a leverage ratio of 0.22.

Item 2026 2025 2024 2020 2019

Assets

Total Assets 208 192 171 55 41
Current Assets 0 0 0 0 0
Fixed Assets 105 95 81 20 15

Liabilities

Total Liabilities 0 0 0 0 0
Current Liabilities 23 31 30 3 1
Non-Current Liabilities 0 0 0 0 0

Shareholders' Equity

Total Equity 163 145 122 42 34
Share Capital 13 13 13 9 9
Reserves & Surplus 150 132 109 33 25

Shree Ganesh Remedies Income Statement Screener - Profit & Revenue Analysis

Screen Shree Ganesh Remedies income statement and profit fundamentals. Analyze SGRL quarterly results. Shree Ganesh Remedies reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹34 and net profit was ₹6, equal to earnings per unit of ₹4.88, at an operating margin of 34%.

In that period expenses were ₹22, interest cost ₹1 and tax ₹3. The next period listed, 2026-Jun, shows revenue of ₹15 and net profit of ₹1.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2021-Mar 2021-Jun 2021-Sept 2021-Dec

Revenue and Expenses

Revenue 34 15 25 27 25 31 22 39 25 33 28 16 14 17 22
Expenses 22 11 19 15 17 21 14 20 17 21 17 10 10 13 15

Operating Costs and Margins

EBITDA 12 4 5 12 8 10 7 18 9 12 11 5 4 5 7
Operating Profit % 34.00% 23.00% 17.00% 40.00% 30.00% 32.00% 32.00% 45.00% 33.00% 35.00% 37.00% 33.00% 24.00% 26.00% 27.00%
Depreciation 3 2 3 2 2 3 3 2 2 2 3 1 1 1 1
Interest 1 0 1 1 1 1 1 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 9 2 2 9 5 7 4 16 6 9 8 4 3 4 6
Tax 3 0 1 2 1 2 1 4 2 2 2 1 1 1 1
Net Profit 6 1 2 7 4 5 3 13 5 6 5 3 2 3 4
EPS 4.88 0.87 1.27 5.13 2.68 3.86 2.41 10.01 3.62 4.97 4.22 3.03 4.68 3.02 3.50

Shree Ganesh Remedies Cash Flow Screener - Liquidity Fundamentals

Screen SGRL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹24, and net cash flow was an inflow of ₹4.

Over the same period, investing activities used ₹9 and financing activities used ₹12.

Item 2026-March 2025-March 2024-March 2020-March 2019-March

Cash from Operations and Investing

Operating Activities 24 31 31 5 -5
Investing Activities -9 -36 -33 -3 0

Financing and Net Cash

Financing Activities -12 -1 10 -1 0
Net Cash Flow 4 -6 7 1 -6

Shree Ganesh Remedies Shareholding Pattern Screener

See Shree Ganesh Remedies shareholding pattern with promoter, FII, and DII holdings. Check Shree Ganesh Remedies promoter holding and ownership changes for SGRL on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 72.84%, foreign institutions 0.00%, domestic institutions 0.00% and the public 24.97%, spread across 8,058 shareholders.

The shareholder count was 8,058 in 2026-Mar, compared with 7,822 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 72.84% 72.84% 72.84% 72.80% 72.80% 72.80% 72.80% 69.33%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.01% 0.01% 0.01% 0.00% 0.00%
DII Holding 0.00% 0.52% 0.99% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 24.97% 24.63% 24.07% 24.89% 24.87% 24.92% 24.95% 28.14%
Other Holding 2.19% 2.01% 2.10% 2.31% 2.32% 2.27% 2.25% 2.53%
Shareholder Count 8,058 7,822 8,234 8,978 9,166 8,752 8,442 7,049

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Shree Ganesh Remedies. Shree Ganesh Remedies dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.50 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.50 0.07%
2023-March ₹0.30 0.04%
2022-March ₹0.50 0.20%
2021-March ₹1.75 0.59%
2020-March ₹1.50 0.54%
2019-March ₹1.25 2.32%
2018-March ₹1.00 2.49%
2017-March ₹0.00 0.00%

Shree Ganesh Remedies Stock Index Membership - Nifty & Sensex

See which indices include Shree Ganesh Remedies stock. Check SGRL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Shree Ganesh Remedies is not part of any tracked indices.
Only major market indices are tracked in our system.

Shree Ganesh Remedies Market Events Screener - Corporate Actions

Get Shree Ganesh Remedies corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Shree Ganesh Remedies stock events that may affect SGRL share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 31, 2026, with a record date of October 31, 2026.

It is followed by Annual General Meeting dated September 12, 2026 and Quarterly Result Announcement dated August 12, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-10-31 2026-10-31 Quarterly Result Announcement NA -2.50%
2026-09-12 2026-09-12 Annual General Meeting NA 26.13%
2026-08-12 2026-08-12 Quarterly Result Announcement NA 0.29%
2026-05-14 2026-05-14 Quarterly Result Announcement NA -5.03%
2026-04-06 2026-04-06 Extraordinary General Meeting NA -6.96%
2026-01-23 2026-01-23 Quarterly Result Announcement NA -3.18%
2025-11-07 2025-11-07 Quarterly Result Announcement NA -0.77%
2025-09-09 2025-09-09 Annual General Meeting NA 4.64%
2025-08-01 2025-08-01 Quarterly Result Announcement NA -3.35%
2025-05-19 2025-05-19 Quarterly Result Announcement NA 3.44%
2025-02-05 2025-02-05 Quarterly Result Announcement NA 33.42%
2024-10-29 2024-10-29 Quarterly Result Announcement NA -1.34%
2024-09-30 2024-09-30 Annual General Meeting NA -5.12%
2023-09-07 2023-09-07 Dividend ₹ 0.50 /share 52.75%
2023-02-03 2023-02-03 Rights 7:100 -2.38%

Shree Ganesh Remedies Competitors Screener - Peer Stocks Comparison

Screen SGRL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 449,611 40.80 61,674 12.69% 11,565 59.98
Divis Laboratories 295,360 87.70 11,067 13.95% 2,568 67.88
Torrent Pharmaceuticals 176,970 85.00 13,886 20.34% 2,138 49.31
Laurus Labs 126,379 89.90 6,868 22.01% 890 49.19
Zydus Life Science 119,750 27.60 27,658 17.64% 5,026 52.87
Dr Reddys Laboratories 115,520 41.80 35,059 3.90% 4,158 69.34
Cipla 112,123 39.50 29,045 2.24% 3,870 55.82
Mankind Pharma 108,003 47.90 14,636 14.85% 1,938 63.62
Aurobindo Pharma 103,206 25.80 34,145 5.56% 3,503 60.38
Lupin 89,089 17.30 29,039 26.75% 5,356 44.23

Shree Ganesh Remedies Company Announcements - News & Reports Screener

Screen SGRL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 17, 2026.

The next most recent announcements are dated November 14, 2026 and November 1, 2026.

Date Update Actions
2026-11-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-11-14 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-11-01 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-01 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-11-01 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-31 Results - Financial Results For Quarter And Half Year Ended September 30 2026 -
2026-10-31 Board Meeting Outcome for Outcome Of Board Meeting -
2026-10-27 Board Meeting Intimation for The Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026 -
2026-10-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-03 Appointment of Company Secretary and Compliance Officer -
2026-10-03 Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer -
2026-10-03 Board Meeting Outcome for Outcome Of Board Meeting -
2026-09-26 Closure of Trading Window -
2026-09-12 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-12 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-21 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-20 Reg. 34 (1) Annual Report. -
2026-08-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-13 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-08-13 Announcement under Regulation 30 (LODR)-Press Release / Media Release -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹616.60, within a 52-week range of ₹501.05 to ₹735.55. The P/E ratio is 65.40 and the P/B ratio is 4.77, with earnings per unit of ₹13.83. Market capitalisation stands at ₹793.07 Cr and the dividend yield is 0.08%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 19, 2026. This page covers 5 balance sheet periods, 15 income statement periods, 5 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.